Oncologic Critical Care

ISBN-13: 9783319745879 / Angielski / Twarda / 2019 / 2099 str.

Joseph L. Nates; Kristen J. Price

Opis

Comprised of over 100 chapters, the text explores such topics as the organization and management of an oncologic ICU, diseases and complications encountered in the oncologic ICU, multidisciplinary care, surgical care, transfusion medicine, special patient populations, critical care procedures, ethics, pain management, and palliative care.

Spis treści

Part 1. Organization and Management of an Oncologic Critical Care Unit

1. Oncologic Critical Care Department Organization 

2. Critical Care Staffing 

3. ICU Admission and Discharge Criteria 

4. Quality Assurance and Improvement 

5. ICU Utilization 

6. Current Trends in ICU Beds, Use, Occupancy, and Costs in the United States 

7. Early Warning Systems for the ICU

8. Patient Risk Prediction Model (Severity of Illness Scores) 

Part 2. Multidisciplinary Care 

9. Rapid Response Team 

10. Nursing

11. Pharmacy 

12. Nutrition 

13. Physical and Occupational Therapy

14. Patient Support

15. Advocacy and Social Work

16. Chaplaincy 

Part 3. Advance Practice Providers 

17. Role of the APPs in the Onco-ICU

18. Credentialing

19. Competencies

Part 4. Clinical Pharmacy 

20. Chemotherapy 

21. Considerations for Medications Commonly Utilized in the Oncology Population

22. Supportive Care Considerations

Part 5. Dermatologic Complications

 

23. GHVD, TEN, and Mycosis Fungoides 

Part 6. Neurologic Diseases 

24. Medication-induced Neurotoxicity 

25. Delirium and Psychosis 

26. Seizures and Status Epilepticus 

27. Stroke 

28. Increased Intracranial Pressure (brain mets, ich, hydrocephalus, etc) 

29. Posterior Reversible Encephalopathy Syndrome (PRES) 

30. Tumor-related Diseases/Neoplastic Meningitis/Leptomeningeal Disease   

31. Frequent CNS Infections in the Immunosuppressed Patient 

32. Intracranial Hemorrhage Focused on Cancer and Hemato-oncologic Patients

33. Spinal Cord Compression 

34. TCD in the ICU 

Part 7. Respiratory Diseases 

35. Acute and Chronic Respiratory Failure 

36. Oxygen therapy (low-flow and high-flow oxygen therapy) 

37. Respiratory Care of the Critically Ill Patient  

38. Management of Tracheobronchial Diseases 

39. Pulmonary Hypertension 

40. ARDS and the differential diagnosis of pulmonary infiltrates in the cancer patient

41. Diffuse Alveolar Hemorrhage 

42. Differentiation (Retinoic acid ATRA) Syndrome 

43. Late Non Infectious Pulmonary Complications in Hematopoietic Stem Cell Transplantation 

44. Treatment-related Lung Injury  

45. Pneumonia in the Cancer Patient 

46. Ventilatory Strategies and Weaning from Mechanical Ventilation 

47. Noninvasive Ventilation 

48. High Frequency Ventilation 

49. Prone Ventilatory Therapy 

50. Bi-Level and Airway Pressure Release Ventilation 

51. NAVA 

52. ECMO in Cancer Patients 

53. Tracheostomy: Appropriateness and Indications in Cancer Patients 

54. Pleural Disease, Malignant and Benign Pleural Effusions

55. Sleep Disorders in the Oncologic ICU 

Part 8. Cardiovascular Diseases

56. Hemodynamic evaluation

57. Acute Coronary Syndrome Thrombocytopenia and Antiplatelet Therapy in the Cancer Patient 

58. Interventional Cardiology in the Cancer Patient 

59. Arrhythmias in the Cancer Patient 

60. Management of Pericardial Effusions/Tamponade 

61. Chemotherapy-related Cardiovascular Complications 

62. Cardiopulmonary Resuscitation in the Cancer Patient 

Part 9. Gastrointestinal Disease 

63. Gastrointestinal Bleeding 

64. Malignant Ascites 

65. Hepatobiliary Disease

66. Acute abdomen in the cancer patient 

Part 10. Genitourinary Disease 

67. Hematuria

68. Hemorrhagic cystitis

69. Obstructive Uropathy in the Cancer Patient

Part 11. Renal Disease 

70. Acute Renal Failure

71. Renal Replacement Therapy 

Part 12. Metabolic/Endocrine Complications 

72. Adrenal Emergencies 

73. Carcinoid Crises 

74. Thyroid Emergencies  

75. Electrolytic Abnormalities 

76. Hypoglycemia and Hyperglycemia in the Cancer Patient 

Part 13. Hematologic Diseases 

77. Malignant Hematological Diseases

78. Benign Hematological Diseases  

79. Immunology and molecular biology for the intensivist 

Part 14. Transfusion Medicine 

80. Statistics 

81. Blood Products 

82. Transfusion Reactions 

83. Transfusion Related Lung Injury 

84. Alternatives to Blood Products

85. Massive Bleeding Protocol 

86. Transfusion Thresholds 

Part 15. Vascular Complications 

87. Management of Arterial Bleeding  

88. Prevention and Management of Venous Thromboembolism in the Cancer Patient 

89. SVC Syndrome 

90. Catheter-related Deep Vein Thrombosis 

Part 16. Infectious Diseases 

91. Infection Control Procedures 

92. Neutropenic Fever 

93. Sepsis and Management of Septic Shock  

94. Management of Multi-Drug Resistant Organisms 

95. Fungal Infections 

96. Viral Infections 

97. Bacterial and Atypical Infections 

98. Catheter and Device Related Infections 

99. Nosocomial Infections and Ventilator Associated Pneumonia 

100. Protozoal Infections in the Cancer Patients

101. Antibiotic Stewardship 

102. Tropical diseases in the cancer patient

103. Soft tissue infections 

Part 17. Post-Surgical Care of the Critically Ill Cancer Patient

104. Neurosurgery

105. Head & Neck Surgery 

106. Plastic Surgery & Flap Graft Management 

107. Thoracic Surgery 

108. GI Surgery 

109. Hepatic Surgery 

110. Pancreatic Surgery 

111. Genitourinary Surgery 

112. Orthopedic Surgery 

113. Interventional Radiology 

114. Radiation Therapy & Gamma Knife Procedures 

115. MRI 

116. Outpatient Surgery 

Part 18. Special Patient Populations 

117. Management of the Pregnant Critically Ill Cancer Patient 

118. Special Considerations of Hemato-Oncologic Critically Ill Patient 

119. Pediatric Cancer Critical Care 

Part 19. Critical Care Procedures 

120. ICU Procedures by APP 

121. Management of the Airway in the Cancer Patient 

122. Use of Ultrasound Guidance 

123. Interventional Radiology Procedures 

Part 20. Ethics 

124. Do Not Resuscitate Orders

125. Ethics Consultation

126. End of Life Care

127. Medical Futility

Part 21. Pain Management, Palliative Care, and Outcomes

128. Acute Pain 

129. Chronic Pain 

130. Substance Withdrawal 

131. Palliative Care in the critically ill cancer patient 

132. Outcomes in Critically Ill Oncologic Patients

O autorze

Dr. Joseph L. Nates is a Professor at the University of Texas MD Anderson Cancer Center. He has lived and practiced medicine in several countries. Currently, he is the Deputy Chair of the Department of Critical Care in the Division of Anesthesiology, Critical Care, and Pain Medicine. Dr. Nates is also the Medical Director of the 70-bed Oncologic Surgical and Medical Intensive Care Units and the Founder and President of the Oncologic Critical Care Research Network (ONCCC-R-NET), a global organization dedicated to the advancement of oncologic critical care research and education. Through his organization, Dr. Nates has been leading the pioneering efforts to establish Oncologic Critical Care as a new subspecialty and disseminate this knowledge worldwide. As the foundation for this objective, he has led and coauthored the first two comprehensive oncologic critical care textbooks, in both Spanish and English languages. He has also established regional and global collaborative networks and organized several Oncologic Critical Care symposiums.

Throughout his career, Dr. Nates has occupied multiple leadership positions and received numerous awards, among them the Presidential Award for “Outstanding Achievement and Leadership for Elimination of Ventilator-Associated Pneumonia” from the Department of Health and Human Services and the four leading Critical Care Societies in the USA in 2012, the “Bill Aston Award for Quality” from the Texas Hospital Association, and Distinguished Service Award in 2015, as well as many other research awards during his career. In 2018, for his contributions to critical care, the American College of Critical Care Medicine awarded him the title Master of Critical Care Medicine. The same year, for his international contributions to the development of Oncologic Critical Care, the Chilean Society of Critical Care and Emergency Medicine awarded him the title International Master of Critical Care Medicine.

Dr. Kristen J. Price was born and raised in New Orleans, Louisiana. She received her undergraduate degree in Marine Science from the University of Tampa followed by a Doctor of Medicine degree from Louisiana State University Medical Center in New Orleans. She completed an Internal Medicine residency, Chief Medical Residency, and Pulmonary and Critical Care fellowship at the University of Texas Health in Houston. Following training, she joined the faculty at the University of Texas MD Anderson Cancer Center and currently holds the title of Professor and Chair, Department of Critical Care and Respiratory Care. Under her leadership, the number of faculty and advance practice providers has grown substantially. She also oversees the Respiratory Care Department and the Section of Integrated Bioethics in Cancer Care. Dr. Price developed the multifaceted “Intensive Care Unit Organizational Infrastructure” to systematically organize, establish, and sustain evidence-based clinical, educational, and research initiatives in the ICU. Her main focus of research has been in the outcomes of critically ill oncology patients, particularly those with hematologic malignancies and respiratory failure. She is an active member of the Society of Critical Care Medicine and currently serves on the “Academic Leaders in Critical Care Medicine” task force. Dr. Price has four grown children and currently resides in Houston, Texas.